Leucettinib-92

Overview

Leucettinib-92 (compound 92) is an inhibitor of DYRK/CLK kinase, The IC 50 s are 147 nM (CLK1), 39 nM (CLK2), 5.2 nM (CLK4), 0.8 μM (CLK3), 124 nM (DYRK1A), 204 nM (DYRK1B), 0.16 μM ( DYRK2 ), respectively. 1.0 μM ( DYRK3 ), 0.52 μM ( DYRK4 ), 2.78 μM (GSK3).

Application

Products | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Obesity | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Urogenital Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Others | Products > Signaling Pathways > CDK | Products > Signaling Pathways > DYRK

Product Information

• Catalog No.: HY-155723
• CAS No.: 2732859-57-1
• Molecular Formula: C21H22N4OS
• Molecular Weight: 378.49
• Purity: 98.54%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (6.61 mM); Clear solution
• Availability: In-stock

Source

Original product source